Clinical Trial Update: Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 study evaluating cryotherapy with in situ immunotherapy for metastatic melanoma (skin).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED